IN2014CN01787A - - Google Patents

Download PDF

Info

Publication number
IN2014CN01787A
IN2014CN01787A IN1787CHN2014A IN2014CN01787A IN 2014CN01787 A IN2014CN01787 A IN 2014CN01787A IN 1787CHN2014 A IN1787CHN2014 A IN 1787CHN2014A IN 2014CN01787 A IN2014CN01787 A IN 2014CN01787A
Authority
IN
India
Prior art keywords
lung cancer
individual
small cell
cell lung
non small
Prior art date
Application number
Other languages
English (en)
Inventor
Mehan Michael Riel
Alex A E Stewart
Rachel M Ostroff
Stephen Alaric Williams
Edward N Brody
Original Assignee
Somalogic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somalogic Inc filed Critical Somalogic Inc
Publication of IN2014CN01787A publication Critical patent/IN2014CN01787A/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57423Specifically defined cancers of lung
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/60Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
IN1787CHN2014 2011-10-24 2011-10-24 IN2014CN01787A (ko)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/057499 WO2013062515A2 (en) 2011-10-24 2011-10-24 Lung cancer biomarkers and uses thereof

Publications (1)

Publication Number Publication Date
IN2014CN01787A true IN2014CN01787A (ko) 2015-05-29

Family

ID=48168748

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1787CHN2014 IN2014CN01787A (ko) 2011-10-24 2011-10-24

Country Status (15)

Country Link
EP (1) EP2771692B1 (ko)
JP (1) JP5986638B2 (ko)
KR (1) KR101921945B1 (ko)
CN (2) CN106168624B (ko)
AU (1) AU2011378427B8 (ko)
BR (1) BR112014006432B8 (ko)
CA (3) CA3006793C (ko)
ES (1) ES2674318T3 (ko)
IL (2) IL231426A (ko)
IN (1) IN2014CN01787A (ko)
MX (1) MX355416B (ko)
NZ (1) NZ621733A (ko)
SG (1) SG11201400375SA (ko)
WO (1) WO2013062515A2 (ko)
ZA (1) ZA201401476B (ko)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104777313B (zh) 2010-07-09 2017-09-26 私募蛋白质体公司 肺癌生物标记及其用途
BR112015027937A2 (pt) * 2013-05-09 2017-07-25 Procter & Gamble método e sistema para avaliação de uma condição de saúde
CN107075545A (zh) 2014-07-30 2017-08-18 哈佛学院院长及董事 探针文库构建
CN104263723B (zh) * 2014-09-15 2017-06-06 南京医科大学 一种与原发性肺癌辅助诊断相关的低频高外显性遗传标志物及其应用
WO2016094330A2 (en) * 2014-12-08 2016-06-16 20/20 Genesystems, Inc Methods and machine learning systems for predicting the liklihood or risk of having cancer
KR102078310B1 (ko) * 2015-09-11 2020-02-19 주식회사 압타머사이언스 비소세포성 폐암 진단용 단백질 바이오마커 패널 및 이를 이용한 비소세포성 폐암 진단 방법
JP6688884B2 (ja) * 2015-11-05 2020-04-28 ビージーアイ シェンチェン 肺腺癌を検出するためのバイオマーカー及びその使用
KR20190008843A (ko) * 2016-03-18 2019-01-25 카리스 싸이언스, 인코포레이티드 올리고뉴클레오티드 프로브 및 이의 용도
KR101853118B1 (ko) * 2016-09-02 2018-04-30 주식회사 바이오인프라생명과학 피험체의 폐암 진단을 위한 복합 바이오마커군, 이를 이용하는 폐암 진단용 키트, 복합 바이오마커군의 정보를 이용하는 방법 및 이를 수행하는 컴퓨팅 시스템
EP4386761A3 (en) * 2016-11-08 2024-09-04 President and Fellows of Harvard College Matrix imprinting and clearing
EP3589959B1 (en) * 2017-03-01 2022-09-07 Roche Diagnostics GmbH Systems, method and computer-readable medium for classifying a biological sample regarding the presence of an analyte
WO2018218150A1 (en) 2017-05-26 2018-11-29 President And Fellows Of Harvard College Systems and methods for high-throughput image-based screening
CN109116023B (zh) * 2018-06-14 2021-06-04 郑州大学第一附属医院 一种肺癌标志物抗-mmp12自身抗体及其应用
CN109470859A (zh) * 2018-11-04 2019-03-15 华东医院 一种外泌体蛋白作为鉴别肺结节良恶性标志物及其应用
US20220341939A1 (en) * 2019-02-15 2022-10-27 Biodesix, Inc. Predictive test for identification of early stage nsclc stage patients at high risk of recurrence after surgery
CN110473167B (zh) * 2019-07-09 2022-06-17 哈尔滨工程大学 一种基于深度学习的尿沉渣图像识别系统及方法
CN112892619B (zh) * 2019-12-04 2022-07-15 香港城市大学深圳研究院 弧形边缘截面的pdms母模、微流控阀和芯片及其制备
KR102613772B1 (ko) * 2021-02-02 2023-12-14 제노마인(주) 폐암 혈액 바이오마커의 검출 방법 및 키트

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000052204A2 (en) * 1999-02-22 2000-09-08 Orntoft Torben F Gene expression in bladder tumors
US6596503B1 (en) * 2000-08-18 2003-07-22 East Carolina University Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof
EP1787122B1 (en) * 2004-08-10 2010-10-06 Oncotherapy Science, Inc. NON-SMALL CELL LUNG CANCER-RELATED GENE, ANLN, AND ITS INTERACTIONS WITH RhoA
CN101283106A (zh) * 2005-07-27 2008-10-08 肿瘤疗法科学股份有限公司 小细胞肺癌的诊断方法
US20080305962A1 (en) * 2005-07-29 2008-12-11 Ralph Markus Wirtz Methods and Kits for the Prediction of Therapeutic Success, Recurrence Free and Overall Survival in Cancer Therapies
US8445198B2 (en) 2005-12-01 2013-05-21 Medical Prognosis Institute Methods, kits and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
US8014957B2 (en) * 2005-12-15 2011-09-06 Fred Hutchinson Cancer Research Center Genes associated with progression and response in chronic myeloid leukemia and uses thereof
EP2090665A2 (en) * 2006-10-20 2009-08-19 Exiqon A/S Novel human microRNAs associated with cancer
GB0803192D0 (en) * 2008-02-22 2008-04-02 Mubio Products Bv SCLC biomarker panel
US10359425B2 (en) * 2008-09-09 2019-07-23 Somalogic, Inc. Lung cancer biomarkers and uses thereof
CN104198709A (zh) * 2008-09-09 2014-12-10 私募蛋白质体公司 肺癌生物标记及其用途
EP2356258A4 (en) 2008-11-17 2012-12-26 Veracyte Inc METHOD AND COMPOSITIONS FOR MOLECULAR PROFILE FOR THE DIAGNOSIS OF ILLNESSES
WO2010065940A1 (en) * 2008-12-04 2010-06-10 The Regents Of The University Of California Materials and methods for determining diagnosis and prognosis of prostate cancer
US9624547B2 (en) * 2010-02-10 2017-04-18 The Regents Of The University Of California Salivary transcriptomic and proteomic biomarkers for breast cancer detection
CN103237901B (zh) 2010-03-01 2016-08-03 卡里斯生命科学瑞士控股有限责任公司 用于治疗诊断的生物标志物
AU2011237669B2 (en) 2010-04-06 2016-09-08 Caris Life Sciences Switzerland Holdings Gmbh Circulating biomarkers for disease

Also Published As

Publication number Publication date
KR20140082840A (ko) 2014-07-02
IL252163A0 (en) 2017-07-31
WO2013062515A3 (en) 2014-04-17
SG11201400375SA (en) 2014-04-28
NZ621733A (en) 2015-05-29
JP5986638B2 (ja) 2016-09-06
CN106168624A (zh) 2016-11-30
MX2014004860A (es) 2014-05-27
AU2011378427B8 (en) 2015-08-27
CA3006793A1 (en) 2013-05-02
MX355416B (es) 2018-04-18
ES2674318T3 (es) 2018-06-28
JP2015501154A (ja) 2015-01-15
EP2771692A4 (en) 2015-08-26
AU2011378427A8 (en) 2015-08-27
BR112014006432B8 (pt) 2022-10-25
CN103890586A (zh) 2014-06-25
BR112014006432B1 (pt) 2021-04-06
CN106168624B (zh) 2018-03-13
AU2011378427B2 (en) 2015-07-16
EP2771692B1 (en) 2018-04-18
KR101921945B1 (ko) 2018-11-26
ZA201401476B (en) 2016-06-29
CA3064363A1 (en) 2013-05-02
AU2011378427A1 (en) 2013-05-16
IL231426A (en) 2017-06-29
CA3064363C (en) 2022-05-17
WO2013062515A2 (en) 2013-05-02
BR112014006432A2 (pt) 2017-04-04
EP2771692A2 (en) 2014-09-03
IL231426A0 (en) 2014-04-30
CA3006793C (en) 2020-02-18
CN103890586B (zh) 2016-06-29
CA2847188C (en) 2020-02-18
CA2847188A1 (en) 2013-05-02

Similar Documents

Publication Publication Date Title
IN2014CN01787A (ko)
MX350533B (es) Biomarcadores de cancer pancreatico y usos de los mismos.
EP3029153A3 (en) Mesothelioma biomarkers and uses thereof
MX355020B (es) Biomarcadores de cancer de pulmon y usos de los mismos.
MX2020004617A (es) Prediccion de riesgo de evento cardiovascular y usos del mismo.
GB2478441A (en) Lung cancer biomarkers and uses thereof
WO2012177945A3 (en) Diagnostic methods for eosinophilic esophagitis
EP2566983A4 (en) SERIAL ANALYSIS OF BIOMARKERS FOR THE DIAGNOSIS OF A DISEASE
BR112012019542A2 (pt) "método para avaliar o estado renal em um indivíduo, medição de um ou mais biomarcadores, e, kit"
EA030186B9 (ru) Способ проведения количественных анализов
WO2014186761A3 (en) Methods for determining responsiveness to an anti-cd47 agent
NZ605698A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2008128043A3 (en) Diagnostic and prognostic methods for renal cell carcinoma
EA201500080A1 (ru) Способ in vitro диагностирования и мониторинга рака
WO2015095862A3 (en) Microrna biomarkers for ovarian cancer
WO2011021041A3 (en) Survival prognostic assay
WO2011137388A3 (en) Identification and use of biomarkers for detection and quantification of the level of radiation exposure in a biological sample
GB201014837D0 (en) Biomarker signatures and uses thereof
NZ608316A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP3135774A3 (en) Complex sets of mirnas as non-invasive biomarkers for kidney cancer
WO2015189591A3 (en) Method and arrays for use in diagnosing early breast cancer
WO2012139052A3 (en) Antibody biomarkers for diabetes
NZ601648A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2014161910A3 (en) Methods and arrays for use in biomarker detection for prostate cancer
WO2012135620A8 (en) Molecular gram stain